Skip to main content
SpringerLink
Log in

Hemodialysis Access: Fundamentals and Advanced Management, the Experience in Taiwan

  • Chapter
  • First Online:
Hemodialysis Access

  • 1575 Accesses

Abstract

Because of the high availability and easy accessibility of medical service, hemodialysis (HD) continues to be the most commonly utilized renal replacement therapy in Taiwan. Among the 67,665 prevalent ESRD patients, more than 60,000 of patients (89.7 %) undergoing in-center HD twice to three times per week. This chapter discusses the management of ESRD and the hemodialysis experience in Taiwan.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yen-Chung Lin C-YH, Chih-Chin Kao, Tzen-Wen Chen, His-Hsien Chen C-CH, Mai-Szu WU. Incidence and prevalence of ESRD in Taiwan Renal Registry Data System (TWRDS): 2005–2012. Acta Nephrol. 2014;28:65–8.

    Google Scholar 

  2. Collins AJ, Foley RN, Gilbertson DT, Chen SC. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int Suppl. 2015;5:2–7.

    Article  Google Scholar 

  3. 財團法人國家衛生研究院. 台灣慢性腎病診療指引. 2015.

    Google Scholar 

  4. Chen HS, Cheng CT, Hou CC, Liou HH, Lim PS. Survival and other clinical outcomes of maintenance hemodialysis patients in Taiwan: a 5-year multicenter follow-up study. Hemodial Int. 2014;18:799–808.

    Article  PubMed  Google Scholar 

  5. Ng YY, Hung YN, Wu SC, Ko PJ. Characteristics and 3-year mortality and infection rates among incident hemodialysis patients with a permanent catheter undergoing a first vascular access conversion. Clin Exp Nephrol. 2014;18:329–38.

    Article  PubMed  Google Scholar 

  6. Smith GE, Gohil R, Chetter IC. Factors affecting the patency of arteriovenous fistulas for dialysis access. J Vasc Surg. 2012;55:849–55.

    Article  PubMed  Google Scholar 

  7. Ng YY, Wu SC, Hung YN, Ko PJ. Effect of demographic characteristics and timing of vascular access maturation on patency in Chinese incident haemodialysis patients. Nephrol Dial Transplant. 2009;24:3447–53.

    Article  PubMed  Google Scholar 

  8. Chen SC, Chang JM, Hwang SJ, et al. Significant correlation between ankle-brachial index and vascular access failure in hemodialysis patients. Clini J Am Soc Nephrol. 2009;4:128–34.

    Article  CAS  Google Scholar 

  9. Chou CY, Liu JH, Kuo HL, et al. The association between pulse pressure and vascular access thrombosis in chronic hemodialysis patients. Hypertens Res. 2009;32:712–5.

    Article  CAS  PubMed  Google Scholar 

  10. Vanholder R, Schepers E, Pletinck A, Nagler EV, Glorieux G. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol. 2014;25:1897–907.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Wu CC, Hsieh MY, Hung SC, et al. Serum Indoxyl Sulfate Associates with Postangioplasty Thrombosis of Dialysis Grafts. J Am Soc Nephrol. 2015;27:1254–64.

    Article  PubMed  Google Scholar 

  12. Zoccali C, Bode-Boger S, Mallamaci F, et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet. 2001;358:2113–7.

    Article  CAS  PubMed  Google Scholar 

  13. Wu CC, Wen SC, Yang CW, Pu SY, Tsai KC, Chen JW. Plasma ADMA predicts restenosis of arteriovenous fistula. J Am Soc Nephrol. 2009;20:213–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Wu CC, Huang PH, Lai CL, Leu HB, Chen JW, Lin SJ. The impact of endothelial progenitor cells on restenosis after percutaneous angioplasty of hemodialysis vascular access. PLoS One. 2014;9:e101058.

    Google Scholar 

  15. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92:827–39.

    Article  CAS  PubMed  Google Scholar 

  16. Lin CC, Yang WC, Chung MY, Lee PC. Functional polymorphisms in matrix metalloproteinases-1, −3, −9 are associated with arteriovenous fistula patency in hemodialysis patients. Clin J Am Soc Nephrol. 2010;5:1805–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Exner M, Schillinger M, Minar E, et al. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther. 2001;8:433–40.

    Article  CAS  PubMed  Google Scholar 

  18. Kaneda H, Ohno M, Taguchi J, et al. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol. 2002;22:1680–5.

    Article  CAS  PubMed  Google Scholar 

  19. Schillinger M, Exner M, Mlekusch W, et al. Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm. Thromb Res. 2002;106:131–6.

    Article  CAS  PubMed  Google Scholar 

  20. Lin CC, Yang WC, Lin SJ, et al. Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients. Kidney Int. 2006;69:165–72.

    Article  CAS  PubMed  Google Scholar 

  21. Osborn G, Escofet X, Da Silva A. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts. Cochrane Database Syst Rev. 2008;(4):CD002786.

    Google Scholar 

  22. Dember LM, Beck GJ, Allon M, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008;299:2164–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Capon A, Mordon S. Can thermal lasers promote skin wound healing? Am J Clin Dermatol. 2003;4:1–12.

    Article  PubMed  Google Scholar 

  24. Yu SY, Chiu JH, Yang SD, Hsu YC, Lui WY, Wu CW. Biological effect of far-infrared therapy on increasing skin microcirculation in rats. Photodermatol Photoimmunol Photomed. 2006;22:78–86.

    Article  CAS  PubMed  Google Scholar 

  25. Akasaki Y, Miyata M, Eto H, et al. Repeated thermal therapy up-regulates endothelial nitric oxide synthase and augments angiogenesis in a mouse model of hindlimb ischemia. Circ J. 2006;70:463–70.

    Article  CAS  PubMed  Google Scholar 

  26. Imamura M, Biro S, Kihara T, et al. Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors. J Am Coll Cardiol. 2001;38:1083–8.

    Article  CAS  PubMed  Google Scholar 

  27. Ikeda Y, Biro S, Kamogawa Y, et al. Repeated sauna therapy increases arterial endothelial nitric oxide synthase expression and nitric oxide production in cardiomyopathic hamsters. Circ J. 2005;69:722–9.

    Article  CAS  PubMed  Google Scholar 

  28. Kihara T, Biro S, Ikeda Y, et al. Effects of repeated sauna treatment on ventricular arrhythmias in patients with chronic heart failure. Circ J. 2004;68:1146–51.

    Article  PubMed  Google Scholar 

  29. Lin CC, Chang CF, Lai MY, Chen TW, Lee PC, Yang WC. Far-infrared therapy: a novel treatment to improve access blood flow and unassisted patency of arteriovenous fistula in hemodialysis patients. J Am Soc Nephrol. 2007;18:985–92.

    Article  PubMed  Google Scholar 

  30. Lin CC, Liu XM, Peyton K, et al. Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1. Arterioscler Thromb Vasc Biol. 2008;28:739–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Chen YH, Chau LY, Lin MW, et al. Heme oxygenase-1 gene promotor microsatellite polymorphism is associated with angiographic restenosis after coronary stenting. Eur Heart J. 2004;25:39–47.

    Article  PubMed  Google Scholar 

  32. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006;86:583–650.

    Article  CAS  PubMed  Google Scholar 

  33. Durante W. Heme oxygenase-1 in growth control and its clinical application to vascular disease. J Cell Physiol. 2003;195:373–82.

    Article  CAS  PubMed  Google Scholar 

  34. Durante W, Johnson FK, Johnson RA. Role of carbon monoxide in cardiovascular function. J Cell Mol Med. 2006;10:672–86.

    Article  CAS  PubMed  Google Scholar 

  35. Lin CC, Chung MY, Yang WC, Lin SJ, Lee PC. Length polymorphisms of heme oxygenase-1 determine the effect of far-infrared therapy on the function of arteriovenous fistula in hemodialysis patients: a novel physicogenomic study. Nephrol Dialy Transplant. 2013;28:1284–93.

    Article  Google Scholar 

  36. Lin CC, Yang WC, Chen MC, Liu WS, Yang CY, Lee PC. Effect of far infrared therapy on arteriovenous fistula maturation: an open-label randomized controlled trial. Am J Kidney Dis. 2013;62:304–11.

    Article  PubMed  Google Scholar 

  37. Lai CC, Fang HC, Mar GY, Liou JC, Tseng CJ, Liu CP. Post-angioplasty far infrared radiation therapy improves 1-year angioplasty-free hemodialysis access patency of recurrent obstructive lesions. Eur J Vasc Endovasc Surg. 2013;46:726–32.

    Article  PubMed  Google Scholar 

  38. Wu LC, Lin MY, Hsieh CC, et al. Planned creation of vascular access saves medical expenses for incident dialysis patients. Kaohsiung J Med Sci. 2009;25:521–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Department of Medicine, Cheng Hsin General Hospital, Taipei, Taiwan, Republic of China

    Shang-Feng Yang MD

  2. Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China

    Kuo-Hua Lee MD & Chih-Ching Lin MD, PhD

  3. School of Medicine, National Yang Ming University, Taipei, Taiwan, Republic of China

    Shang-Feng Yang MD, Kuo-Hua Lee MD & Chih-Ching Lin MD, PhD

Authors
  1. Shang-Feng Yang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kuo-Hua Lee MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chih-Ching Lin MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chih-Ching Lin MD, PhD .

Editor information

Editors and Affiliations

  1. Division of Vascular Surgery, Department of Surgery The University of Washington, Seattle, Washington, USA

    Sherene Shalhub

  2. Department of Surgery, Medical College of Wisconsin, Brookfield, Wisconsin, USA

    Anahita Dua

  3. Division of Vascular Surgery, Department of Surgery The University of Washington, Seattle, Washington, USA

    Susanna Shin

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Yang, SF., Lee, KH., Lin, CC. (2017). Hemodialysis Access: Fundamentals and Advanced Management, the Experience in Taiwan. In: Shalhub, S., Dua, A., Shin, S. (eds) Hemodialysis Access. Springer, Cham. https://doi.org/10.1007/978-3-319-40061-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-40061-7_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-40059-4

  • Online ISBN: 978-3-319-40061-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation